Patents Assigned to Lotus BioPharma Inc.
  • Publication number: 20240315971
    Abstract: This disclosure provides injectable microsphere formulations capable of controlled long-term sustained release. The disclosed microsphere formulations demonstrate a zero-order release of active agents over a predetermined period of time. Also disclosed are methods of preparing the microsphere formulations and methods of use thereof. The disclosed methods can be readily scaled up while maintaining a high drug encapsulation efficiency.
    Type: Application
    Filed: March 1, 2024
    Publication date: September 26, 2024
    Applicant: Lotus BioPharma Inc.
    Inventors: Chao Li, Nancy L. Li, Kingteh Lin